Danny Cohn

Sep 24, 2024 | al.com | Danny Cohn

This is a guest opinion columnThe September 15th Op-ed entitled “Reflections on Israel’s war in Gaza” is a prime example of the campaign to delegitimize Israel and the rampant one-sided, ill-informed misinformation that is spreading in our community, on social media, and around the world since October 7th.

Jul 1, 2024 | sciencedirect.com | Remy S. Petersen |Danny Cohn |Johann E. Gudjonsson |Seema S. Aceves

Eosinophilic gastritis (EoG) is a chronic, food antigen–driven inflammatory disorder associated with type 2 immunity.1, 2, 3 EoG is characterized by eosinophil accumulation in the stomach, typically associated with endoscopic and histopathologic changes.1,3 As eosinophil accumulation is a main feature of EoG and serves as the criterion standard for EoG diagnosis, clinical studies have begun investigating the impact of antieosinophil therapy using antibodies targeting eosinophils.

Jul 1, 2024 | sciencedirect.com | Seema S. Aceves |Glenn T. Furuta |Remy S. Petersen |Danny Cohn

Section snippetsPatients and samplesSkin biopsy samples were taken from healthy acral control skin of 10 volunteers (5 palms, 5 soles), healthy nonacral skin of 5 volunteers, and nonmatched lesional skin of patients with PPP (n = 33), palmPP (n = 5), and DPE (n = 28). Table E1 in this article’s Online Repository (available at www.jacionline.org) lists patients’ characteristics.

Jul 1, 2024 | sciencedirect.com | Jorge Maspero |Megan Hardin |Remy S. Petersen |Danny Cohn

Previous randomized controlled trials have established the efficacy of dupilumab among patients with chronic obstructive pulmonary disease (COPD) treated with triple therapy over 52 weeks of follow-up. This population-based cohort study aimed to explore the long-term safety and effectiveness of dupilumab in patients with COPD. The study included US patients with COPD who were seen between April 2017 and August 2024.